chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe neck pain on the same side as vaccination site that is lasting more than two weeks after second dose.; This is a spontaneous report from a non-contactable consumer. This 35-year-old female consumer reported for herself that.  A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 21Jun2021 14:00 as (At the age of 35-years) dose 2, single for covid-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing and Known allergies to Penicillin from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. Patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 28May2021 04:00 pm as (At the age of 35-years) dose 1, single for covid-19 immunisation. The patient experienced severe neck pain on the same side as vaccination site that is lasting more than two weeks after second dose on 22Jun2021. Patient visit Physician Office for event and received treatment as Physical therapy and pain medication. The outcome of event was not recovered.   No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
My first dose went fine had a sore arm for about a week. My second doee on April 1 went fine at first just soreness however after 7 days I woke up and found the upper part of my arm was a solid dark purple to Black, it continue to spread down to my elbow the following day and was extremely sore.It went a little past my elbow and has not gone any further.
Son started to experience pain and swelling in hands and feet. Started with finger swelling and rapidly spread all over body. My son is currently unable to attend school and barely can walk. Has elevated liver enzymes.
Positive for Covid 19 virus after receiving Covid 19 vaccine; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 03Jan2021 as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 13Jan2021, the patient tested positive for COVID 19 virus after receiving COVID 19 vaccine on 03Jan2021. The patient underwent lab tests and procedures which included SARS-COV-2 test: positive on 13Jan2021. Clinical outcome of the event was unknown.  Information about the lot/batch number has been requested.
had the same tingly arm sensations but they were more mild but not as bad as the second shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71-year-old female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "allergic to wool" (unspecified if ongoing), notes: she's allergic to wool; "She has a lot of allergies" (unspecified if ongoing), notes: She has a lot of allergies. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for Covid-19 immunization, reaction(s): "she was fine"; Bnt162b2 (Dose 2, single), for Covid-19 immunization, reaction(s): "she felt something itchy on the left underside of her arm"; Bnt162b2 (Dose 3 (Booster), single), for Covid-19 immunization, reaction(s): "she had the same tingly arm sensations". The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "had the same tingly arm sensations but they were more mild but not as bad as the second shot".  Additional information: patient did have some side effects after the Pfizer BioNTech Covid 19 vaccines, she received the first two initial doses as well as both boosters, and all shots were Pfizer. When she got the first vaccination she was fine. After the second vaccination, within 15 minutes or so she felt something itchy on the left underside of her arm. It was about a year and half ago in the winter and she was wearing a wool sweater and she's allergic to wool. She changed to a cotton sweater but the itching continued. It was a weird sensation from armpit to wrist on the underside. Its an unusual sensation, it feels like something under the skin like heebee geebees, creepy crawly sensations, like a mosquito bite but keeps spreading. Within two weeks she had the same feeling on the right side from armpit to wrist. Its always been there but now its subsided. Now with Covid, it has reactivated and flared up again a little bit, now can deal with it. She has a lot of allergies, she used to get allergy shots a long time ago. With the two boosters from Pfizer, she had the same tingly arm sensations but they were more mild but not as bad as the second shot. She became more accustomed to it and knew how to deal with it. She doesn't remember if vaccine was given on left or right side. While waiting after the injection she was fine but after she got in car, she felt weird little mosquito bite, and then started to grow. Sensation never went away 100% but subsided and got tolerable. When she got Covid, all of a sudden it came back, a twingy feeling under both arms. She takes no medications and is very healthy.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038k20a) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). On 05-Feb-2021, DIARRHOEA (Diarrhea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Patchy clusters or individual spots. Last 2-3 weeks.; This is a spontaneous report from a contactable female consumer (patient reported for herself). A 74-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 74-year-old) at a 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive other vaccines prior to the COVID vaccine within 4 weeks. The patient experienced patchy clusters or individual spots last 2-3 weeks on an unspecified date. AE resulted in doctor or other healthcare professional office/clinic visit. The patient had not tested for COVID-19 post vaccination. The patient did not receive any treatment for the events. Outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Following vax pt developed injection abscess; no surgical intervention required; PO antibiotic prescribed; pt asymptomatic & area non tender; only pea size node;
Patient had vaccine on Thursday afternoon and reported that during the evening he started to have severe pain (pain scale 7) on his left shoulder blade and surrounding muscle. He took 400mg of ibuprofen and went to sleep. The next day he still had pain but it was less severe (pain scale 4) and at time of reporting he had some pain but it was less severe (pain scale 2).
sore throat; sore muscle; headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), MYALGIA (sore muscle) and HEADACHE (headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Nov-2021, the patient experienced MYALGIA (sore muscle) and HEADACHE (headache). On 12-Nov-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat), MYALGIA (sore muscle) and HEADACHE (headache) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
eczema; red streaks underneath the fingernail; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (eczema) and SPLINTER HAEMORRHAGES (red streaks underneath the fingernail) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD, Emphysema and Arthritis.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced ECZEMA (eczema) and SPLINTER HAEMORRHAGES (red streaks underneath the fingernail). At the time of the report, ECZEMA (eczema) and SPLINTER HAEMORRHAGES (red streaks underneath the fingernail) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant drugs were not reported.  Treatment medications included topical cream.  In September 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. It was reported that patient was receiving care from a veteran.   Reporter did not allow further contact
Soreness, loss of appetite, chills, spasmodic diarrhea, insomnia.
Her face was bright red on both sides and the neck; Looked like she was burned; Felt her leg got licked; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Her face was bright red on both sides and the neck), ERYTHEMA (Looked like she was burned) and FEELING ABNORMAL (Felt her leg got licked) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 28-Feb-2021, the patient experienced ERYTHEMA (Her face was bright red on both sides and the neck), ERYTHEMA (Looked like she was burned) and FEELING ABNORMAL (Felt her leg got licked). At the time of the report, PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Her face was bright red on both sides and the neck), ERYTHEMA (Looked like she was burned) and FEELING ABNORMAL (Felt her leg got licked) outcome was unknown.
This spontaneous report as received from a health care professional refers to a patient of unknown age. On 13-AUG-2012, the patient was vaccinated with MMR II lot # 0582Z exp date; 11-AUG-2012. No symptoms reported. Additional information has been requested.
This spontaneous report was received from a physician, via a company representative, concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 26-FEB-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2018, 0.5 ml (route and anatomical location of administration were not reported). On unspecified dates, the PNEUMOVAX 23 vaccine had six temperature excursions of 0 Celsius Degrees (32 Fahrenheit) for 256 hours, 0.55 Celsius Degrees (33 Fahrenheit) for 128 hours, -1.11 Celsius Degrees (30 Fahrenheit) for 288 hours, -1.66 Celsius Degrees (29 Fahrenheit) for 256 hours, -0.55 Celsius Degrees (31 Fahrenheit) for 552 hours, and 1.11 Celsius Degrees (34 Fahrenheit) for 48 hours, respectively. The vaccine status was reported as "in excursion" and the type of excursion and storage criteria were reported as "refrigerator (R)". No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
I am having consistent and chronic headaches well over a week later.  Have never suffered from headaches like this after the 2nd injection.  Had the headaches stopped within 48-72 hours after the injection this wouldn't be a big deal, but I am still having bad headaches 8 days later.  Tylenol sometimes helps a little, but sometimes it doesn't.  I am concerned about my long term health.
He was given the Moderna COVID vaccine first dose on 1-15-2021.  2.5 weeks later he complained of constant abdominal pain that lasted two days. No fever/chills, nausea/vomiting, diarrhea/constipation, no visible blood in stool or urine, no abnormal color or volume of urine. No preceding illness of any kind.  He is tested for COVID weekly at college and was always negative including on 1-16-2021   He went to a freestanding ER where CT Abd without contrast showed normal appendix but mesenteric adenitis.  White count was normal but creatinine was 2.8!   He was given 2 L of fluid and recheck showed Cr 2.8 again. Urine dipstick 2+ proteinuria and microscopic hematuria.  He works out 6 days/week but nothing unusual in the recent workout history.  CPK was normal.  Serum myoglobin slightly elevated at 94.  He doesn?t take supplements, creatine, drugs, energy drinks, coffee or any medications. He was advised to hydrate copiously which he did.    He was admitted for work up two days later.  Repeat Cr was 3.1. ESR was 45 and CRP 2.26.   RF, ANA, ANCA negative.  Complement levels C3 and C4 normal.  Uric acid and LDH normal.  Amylase and Lipase normal.   UA showed no protein or blood.  IVF given overnight and kidney biopsy planned for the next day depending on that mornings labs.    That morning Cr came down to 2.4.   PTH was 127, Vit D 12.7, Calcium normal.  SPEP normal and UPEP normal.  Urine drug screen normal.    Kidney biopsy cancelled and he was discharged.    Cr two days later (2-10-2021) was 1.68
No significant events, tired and achy  11//09/21 EYELID DROOP 11/15/21 Slurring of speech.  Difficult swallowing,
Patient received her first Covid-19 vaccine on 2/15. She did well with it.  However, 3 days later she developed redness and itching at the site of vaccination on the left upper arm. It has slightly gotten worse since then.
Pain behind her right eye that won't go away; developing a throbbing headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN and HEADACHE in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 023M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included MYRBETRIQ, ESTRADIOL ACETATE, and LORATADINE for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EYE PAIN and HEADACHE. The patient was treated with GABAPENTIN for Adverse event, at an unspecified dose and frequency; TYLENOL for Adverse event, at an unspecified dose and frequency, and ALEVE for Adverse event, at an unspecified dose and frequency. At the time of the report, EYE PAIN and HEADACHE had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had undergone MRI and CT scans but with no resolution. The symptoms were ongoing.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 75-year-old female patient who received SHINGRIX for prophylaxis. On 13th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 13th February 2019, less than a day after receiving SHINGRIX, the patient experienced pain in arm and tenderness. On 14th February 2019, the patient experienced headache, chills, fever, erythema, pain and swelling. The patient was treated with ADVIL and Cold Compress. On an unknown date, the outcome of the headache, pain, pain in arm and tenderness were unknown and the outcome of the chills and fever were recovered/resolved and the outcome of the erythema and swelling were not recovered/not resolved. It was unknown if the reporter considered the headache, chills, fever, erythema, pain, swelling, pain in arm and tenderness to be related to SHINGRIX. Addition details were received as follows: At 10:30 am, the patient received SHINGRIX in the left arm. On the day of vaccination, she experienced achy arm and tenderness to touch. On the next day after vaccination, the patient experienced headache, chills, fever, redness, soreness and swelling. On the day of reporting, the redness and swelling was worse and it was present around the outside of the upper arm covering an area of 6 inches by 6 inches. The patient was taking ADVIL and applying cold compress to the area. The patient was not able to tolerate the cold compress and could not sleep on the side of the arm. The chills and fever lasted for about 1 day. The reporter did not consent to follow up.
Woke up in the middle of the night and couldn't breathe. Couldn't walk and talk at the same time for 3 days. Had no energy because it was too hard to breathe. Was put in the hospital for 3 days, checking on lungs and heart. Had chest X-rays etc. Could not come up with  definite reason, but my condition did not improve. I was put on 2 liter of oxygen (which I was never on prior to shot), and told to see doctor in 7 days.
On 1/19/07 approx about 9pm started to feel chills and muscle cramps. On 1/18/07 1am-woke up due to muscle cramps, chills. Temp was 103, treated with tylenol every 4 hours, which ended 1/19/07. Also did hae nausea
Marked regression with coordination (falling down when previously walking very well) and eye contact (staring into space and up a lot). Less alert. For over 3 weeks. Holistic Treatment administered to help with vaccine reactions which made significant improvements. Apraxia. Speech therapy to treat apraxia. Today he has ADHD type signs and symptoms.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information on patient's pertinent medical history and concurrent condition was not reported. On an unspecified date of 2016 after 19-NOV-2016, the patient was vaccinated with improperly stored GARDASIL 9 (dose and route not reported). The reporting nurse was not sure about which lot was administered, if L019297 expiry date 18-AUG-2017 or M007764 expiry date 30-JAN-2018 was involved. There was no previous excursion reported. Temperature/Time: 31.3F for 64 hours.  Digital data logger was used. No further information was provided. Additional information has been requested.
Became lethargic and had malaise, called 911 and could only be heard breathing on the line. When EMS arrived, she was deceased.
Got sick; This case was reported by a consumer via call center representative and described the occurrence of sickness in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.     Additional Information: GSK receipt date: 28-NOV-2022 Reporter's comment: The reporter reported that her brother in law got sick after getting the shingrix shot.  No other information was reported to the agent by the caller.  The reporter did not consent to follow-up.
Information has been received from a pharmacist concerning five patients of unknown age and gender, who on an unspecified dates were vaccinated with lot # (671786/0254AE; Exp: 08-MAR-2013) ZOSTAVAX (doses and routes not reported) and developed a similar injection site reaction described as a rash following vaccination (all five patients were reported to have received the same lot of ZOSTAVAX.  No other co-suspects were reported. No concomitant medications were reported.  The five patients were reported to have developed a hot, raised, red, itchy "4 by 4" area that was about 2 inches below the injection site (pharmacist called it a rash), but no vesicles or bumps were present. The pharmacist reported that the injection site reaction developed about a day or two after each of the five ZOSTAVAX vaccinations and that the injection site reaction had resolved in all five patients at the time of the call (exact dated of vaccination, development of rash and date of resolution was not available at the time of the call). The pharmacist reported that the five injection site reactions reported with ZOSTAVAX, occurred between this August (2012) and the end of September of this year (2012). The patients sought unspecified medical attention - contacted pharmacist. Additional information has been requested.
severe pain in back; nerve damage; shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), BACK PAIN (severe pain in back) and NERVE INJURY (nerve damage) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HERPES ZOSTER (shingles). On 17-Feb-2021, the patient experienced BACK PAIN (severe pain in back) and NERVE INJURY (nerve damage). At the time of the report, HERPES ZOSTER (shingles), BACK PAIN (severe pain in back) and NERVE INJURY (nerve damage) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details for the events experienced by consumer  included valacyclovir, unspecified oinment, gabapentin   This case was linked to MOD-2021-030878 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: The event outcome update for all event as resolving.; Sender's Comments:  MOD-2021-030878:
4/98 fatigue, insomnia, skin rash, frequent flu sx, irregular heart beat, chest tension & pain, SOB (*feverish, h/a, dizzy), edema;7/98 joint pain (unable to walk upon awakening by 10/98);nervousness, depression, memory loss, dry mouth;
1/30/19 vaccine were given at 12:00 PM. When patient got home started complaining of (R) arm pain. Vomited 6 times from 4pm to 3:00 AM. 1/31/19 - mild stomach pain, Fever of 102 at 2:00 PM, Passing a lot of gas. 1/24/19 - went to see doctor for consult.